The total return over the past 12 months is +95.25% vs. +16.94% for the S&P 500. So far it's up -13.09% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +95.25% | +45.79% | +28.51% | N/A | N/A | N/A |
| Total Return CAGR | +95.25% | +45.79% | +28.51% | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Cogent Biosciences, Inc. (COGT)
| Year | Start price | End price | COGT Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $35.52 | $30.87 | (13.09%) | +14.51% | (27.60%) |
| 2025 | $7.80 | $35.52 | +355.38% | +17.72% | +337.66% |
| 2024 | $5.88 | $7.80 | +32.65% | +24.89% | +7.76% |
| 2023 | $11.56 | $5.88 | (49.13%) | +26.19% | (75.32%) |
| 2022 | $8.58 | $11.56 | +34.73% | (18.17%) | +52.90% |
| 2021 | $11.23 | $8.58 | (23.60%) | +28.74% | (52.34%) |
| 2020 | $2.88 | $11.23 | +289.93% | +18.37% | +271.56% |
| 2019 | $17.60 | $2.88 | (83.64%) | +31.22% | (114.86%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
